We'll see early next week if I talk too much okay? I've been at this game a long time, I say that was a "take down" ahead of NEWS!
If we get news and with the number of Lawyers looking at this yesterday and today shorts will have no choice but cover, this could blow to $12.00+ on positive SPI-2012 results, maybe $15.00??
Watch and learn, yesterday was a ruse for shorts to cover.
Protected by Orphan Drug Designation and 829 Orange Book Patent until 2022. We won both the Markman hearings in Nevada in June 2013 and Delaware July 2014. The Judge ruled almost entirely in our favour on all claim constructs presented. FUSILEV is stripping market share from generic Leucovorin and everyone knows it, we have an extremely valuable asset that has just started combo therapy trials with FOLOTYN as a life cycle management strategy. FUSILEV will be a cash cow for SPPI for years to come. This FDA inquiry happened BEFORE the last Markman hearing in Deleware and has no bearing at this point. Shorts just trying to scare Longs out of their shares, take the drop in price and LOAD UP like I did, we're headed higher. TICK TOCK!
That FDA inquiry was made in March 2014 and May 2014, on July 3rd the Delaware court in a Markman hearing ruled almost entirely in SPPI's favour on claim constructs further to the June 2013 victory in Nevada. ThisFDA inquiry was made when Generics still thought they had a chance to market a drug, but now they realize it's futile so this FDA release is inconsequential. Just do like I did and use the hack attack to load up cheap!
Cover immediately and move on cause the investigation won't take kindly to anyone continuing in this grand larceny
Okay thanks - I'm putting a call into my Lawyer on this